{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:13:41Z","timestamp":1760217221225,"version":"3.34.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,4,12]],"date-time":"2008-04-12T00:00:00Z","timestamp":1207958400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00210-008-0283-x","type":"journal-article","created":{"date-parts":[[2008,4,11]],"date-time":"2008-04-11T09:00:22Z","timestamp":1207904422000},"page":"117-124","source":"Crossref","is-referenced-by-count":2,"title":["Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments"],"prefix":"10.1007","volume":"378","author":[{"given":"A. R.","family":"Owolabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Akanmu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. E.","family":"Ukponmwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,12]]},"reference":[{"issue":"5","key":"283_CR1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0031-9384(97)00169-8","volume":"62","author":"WJ Brooks","year":"1997","unstructured":"Brooks WJ, Weeks AC, Leboutiller JC, Petit TL (1997) Altered NMDA sensitivity and learning following chronic developmental NMDA antagonism. Physiol Behav 62(5):955\u2013962","journal-title":"Physiol Behav"},{"key":"283_CR2","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1126\/science.8099761","volume":"260","author":"SB Caine","year":"1993","unstructured":"Caine SB, Koob GF (1993) Modulation of cocaine self administration in the rat through D3 dopamine receptors. Science 260:1814\u20131816","journal-title":"Science"},{"key":"283_CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0006-8993(95)00229-J","volume":"680","author":"F Calon","year":"1995","unstructured":"Calon F, Goulet M, Blanchet PJ, Martel JC, Piercey MF, Bedard PJ, Di Paolo T (1995) Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex. Brain Res 680:43\u201352","journal-title":"Brain Res"},{"issue":"Suppl. 37","key":"283_CR4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1192\/S0007125000293574","volume":"174","author":"A Carlsson","year":"1999","unstructured":"Carlsson A, Hansson LO, Waters N, Carlsson ML (1999) A glutamatergic deficiency model of schizophrenia. Br J Psychiatry 174(Suppl. 37):2\u20136","journal-title":"Br J Psychiatry"},{"key":"283_CR5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/0306-4522(86)90124-7","volume":"19","author":"A Cheramy","year":"1986","unstructured":"Cheramy A, Romo R, Godeheu G, Baruch P, Glowinski J (1986) In vivo presynaptic control of dopamine release in the cat caudate nucleus, II; Facilitatory or inhibitory influence of l-glutamate. Neuroscience 19:1081\u20131090","journal-title":"Neuroscience"},{"key":"283_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00702-005-0297-1","volume":"113","author":"MB Christensen","year":"2005","unstructured":"Christensen MB, Abdersen MB, Jensen A, Werge T, Gerlach J (2005) The substituted (s)-3-phenylpiperidine-(\u2212)-OSU6162 reduces apomorphine and amphetamine induced behavior in monkeys. J Neural Transm 113:11\u201319","journal-title":"J Neural Transm"},{"key":"283_CR7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ddr.430020203","volume":"2","author":"BV Clineschmidt","year":"1982","unstructured":"Clineschmidt BV, Martin GE, Bunting PR (1982) Anticonvulsant activity of (+)-5-methyl-10, 11-dihydro-5H-dibenzo(a,d)cyclohepten-5,10-imine I (MK801) a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Rev Res 2:123\u2013124","journal-title":"Drug Rev Res"},{"key":"283_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10673229609017192","volume":"3","author":"JT Coyle","year":"1996","unstructured":"Coyle JT (1996) The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatr 3:241\u2013253","journal-title":"Harv Rev Psychiatr"},{"key":"283_CR9","volume-title":"Stimulants: Neurochemical, Behavioral, and Clinical Perspectives","author":"I Creese","year":"1983","unstructured":"Creese I (1983) Stimulants: Neurochemical, Behavioral, and Clinical Perspectives. Raven, New York"},{"key":"283_CR10","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1471-4159.1989.tb07257.x","volume":"52","author":"JFW Deakin","year":"1989","unstructured":"Deakin JFW, Slater P, Simpson MDC, Gilchrist AC, Skan WJ, Royston MC, Reynolds GP, Cross AJ (1989) Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem 52:1781\u20131786","journal-title":"J Neurochem"},{"issue":"95","key":"283_CR11","first-page":"137","volume":"38","author":"G Chiara Di","year":"1995","unstructured":"Di Chiara G (1995) The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 38(95):137","journal-title":"Drug Alcohol Depend"},{"key":"283_CR12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/002204269502500407","volume":"25","author":"J Dotson","year":"1995","unstructured":"Dotson J, Ackerman A, West L (1995) Ketamine abuse. J Drug Issues 25:751\u2013757","journal-title":"J Drug Issues"},{"issue":"7","key":"283_CR13","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1523\/JNEUROSCI.16-07-02172.1996","volume":"16","author":"P Follessa","year":"1996","unstructured":"Follessa P, Ticku M, NMDA (1996) Receptor upregulation: molecular studies in cultured mouse cortical neurons after chronic NMDA antagonist exposure. J Neurosci 16(7):2172\u20132178","journal-title":"J Neurosci"},{"key":"283_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0304-3940(77)90068-4","volume":"6","author":"MF Giorguieff","year":"1977","unstructured":"Giorguieff MF, Kemel ML, Glowinski J (1977) Presynaptic effect of l-glutamic acid on the release of dopamine in the rat striatal slices. Neurosci Lett 6:73\u201377","journal-title":"Neurosci Lett"},{"key":"283_CR15","first-page":"201","volume":"23","author":"A Hiratsuka","year":"1995","unstructured":"Hiratsuka A, Chu TY, Distefano EW, Lin LY, Schmidt DA, Cho AK (1995) Inactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat. Drug Metab Dispos 23:201\u2013206","journal-title":"Drug Metab Dispos"},{"key":"283_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01245347","volume":"89","author":"DC Hoffman","year":"1992","unstructured":"Hoffman DC (1992) Typical and atypical neuroleptics antagonize MK-801 induced locomotion and stereotypy in rats. J Neural Transm Gen Sect 89:1\u201310","journal-title":"J Neural Transm Gen Sect"},{"key":"283_CR17","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"DC Javitt","year":"1991","unstructured":"Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301\u20131308","journal-title":"Am J Psychiatry"},{"key":"283_CR18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0893-133X(97)00047-X","volume":"17","author":"DC Javitt","year":"1997","unstructured":"Javitt DC, Sershen H, Hashim A, Lajtha A (1997) Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycylodecylamide. Neuropsychopharmacology 17:202\u2013204","journal-title":"Neuropsychopharmacology"},{"key":"283_CR19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.npp.1300313","volume":"29","author":"DC Javitt","year":"2004","unstructured":"Javitt DC, Balla A, Burch S, Suckow R, Xie S, Sershen H (2004) Reversal of phencyclidine-induced dopaminergic dysregulation by NMDA receptor\/glycine-site agonists. Neuropsychopharmacology 29:300\u2013307","journal-title":"Neuropsychopharmacology"},{"key":"283_CR20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1471-4159.1994.63020785.x","volume":"63","author":"HP Jedema","year":"1994","unstructured":"Jedema HP, Moghaddam B (1994) Glutamatergic control of dopamine release during stress in rat prefrontal cortex. J Neurochem 63:785\u2013788","journal-title":"J Neurochem"},{"key":"283_CR21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","volume":"20","author":"JD Jentsch","year":"1999","unstructured":"Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201\u2013225","journal-title":"Neuropsychopharmacology"},{"key":"283_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2006.04.026","volume":"540","author":"S Jordan","year":"2006","unstructured":"Jordan S, Chen R, Fernalld R, Johnson J, Regardie K, Kambayashi J, Tadori Y, Kitagawa H, Kikuchi T (2006) In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK801) are inactive at cloned human and rat dopamine D2 receptors. Eur J Pharmacol 540:53\u201356","journal-title":"Eur J Pharmacol"},{"key":"283_CR23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/dmd.31.1.46","volume":"31","author":"MI Jushchyshyn","year":"2003","unstructured":"Jushchyshyn MI, Kent UM, Hollenberg PF (2003) The mechanism-based inactivation of human cytochrome P450 2B6 by phencyclidine. Drug Metab Dispos 31:46\u201352","journal-title":"Drug Metab Dispos"},{"key":"283_CR24","first-page":"378","volume":"251","author":"PW Kalivas","year":"1989","unstructured":"Kalivas PW, Duffy P, Barrow J (1989) Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther 251:378\u2013387","journal-title":"J Pharmacol Exp Ther"},{"key":"283_CR25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0006-8993(76)90039-1","volume":"109","author":"ST Kitai","year":"1976","unstructured":"Kitai ST, Kocsis JD, Preston RJ, Sugimori M (1976) Monosynaptic inputs to caudate nucleus identified by intracellular injection of horsedish peroxidase. Brain res 109:601\u2013606","journal-title":"Brain res"},{"key":"283_CR26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0014-2999(89)90378-6","volume":"166","author":"MO Krebs","year":"1989","unstructured":"Krebs MO, Kernel ML, Gauchy C, Desban M, Glowinski J (1989) Glycine potentiates the NMDA-induced release of dopamine through a strychnine-insensitive site in the rat striatum. Eur J Pharmacol 166:567\u2013570","journal-title":"Eur J Pharmacol"},{"key":"283_CR27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1471-4159.1991.tb02565.x","volume":"56","author":"MO Krebs","year":"1991","unstructured":"Krebs MO, Desce JM, Kemel ML, Gauchy C, Godeheu G, Cheramy A (1991) Glutamatergic control of dopamine release in the striatum: evidence for the support for pre-synaptic NMDA receptors on dopaminergic nerve terminals. J Neurochem 56:81\u201385","journal-title":"J Neurochem"},{"key":"283_CR28","first-page":"345","volume":"145","author":"JH Krystal","year":"1995","unstructured":"Krystal JH, D\u2019Souza C, Laurence KP, Abi-Dargham DA, Karyn N, Bowers MB, Sally V, George RH, Dennis SC (1995) Interactive effects of subanesthetic dose of ketamine and haloperidol in healthy humans. Psychopharmacol 145:345\u2013360","journal-title":"Psychopharmacol"},{"key":"283_CR29","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archpsyc.62.9.985","volume":"62","author":"JH Krystal","year":"2005","unstructured":"Krystal JH, Perry EB Jr, ueorguieva R, Belger A, Madonick SH, Abi-Dargham A, Cooper TB, Macdougall L, Abi-Saab W, D\u2019Souza DC (2005) Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model of psychosis and cognitive dysfunction. Arch Gen Psychiatry 62:985\u2013994","journal-title":"Arch Gen Psychiatry"},{"key":"283_CR30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-3940(91)90255-R","volume":"128","author":"B Lannes","year":"1991","unstructured":"Lannes B, Micheletti G, Warter JM, Kempf E, Di Scala G (1991) Behavioral, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat. Neurosci Lett 128:177\u2013181","journal-title":"Neurosci Lett"},{"key":"283_CR31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/0269881107077712","volume":"21","author":"CH Large","year":"2007","unstructured":"Large CH (2007) Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs? J Psychopharmacol 21:283\u2013301","journal-title":"J Psychopharmacol"},{"key":"283_CR32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(99)00067-0","volume":"46","author":"M Laurelle","year":"1999","unstructured":"Laurelle M, Abi-Dargham A, Gil R, Kegeles LS, Innis R (1999) Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46:56\u201372","journal-title":"Biol Psychiatry"},{"key":"283_CR33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0090-9556(24)15372-X","volume":"28","author":"MY Law","year":"2000","unstructured":"Law MY, Slawson MH, Moody DE (2000) Selective involvement of cytochrome P450 2D subfamily in in vivo 4-hydroxylation of amphetamine in rat. Drug Metab Dispos 28:348\u2013353","journal-title":"Drug Metab Dispos"},{"key":"283_CR34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0006-8993(97)00255-2","volume":"759","author":"N Lindefors","year":"1997","unstructured":"Lindefors N, Barati S, O\u2019Connor W (1997) Differential effects of single and repeated ketamine administration on dopamine, serotonin, and GABA transmission in rat prefrontal cortex. Brain Res 759:202\u2013212","journal-title":"Brain Res"},{"key":"283_CR35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00213-005-2199-1","volume":"179","author":"MJ Millan","year":"2005","unstructured":"Millan MJ (2005) N-methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology 179:30\u201353","journal-title":"Psychopharmacology"},{"key":"283_CR36","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921\u20132927","journal-title":"J Neurosci"},{"key":"283_CR37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0014-2999(83)90170-X","volume":"91","author":"T Nabeshima","year":"1983","unstructured":"Nabeshima T, Yamada K, Yamaguchi K, Hiramatsu M, Furukawa H, Kameyama T (1983) Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotype behaviors and hyperactivity in rats. Eur J Pharmacol 91:455\u2013462","journal-title":"Eur J Pharmacol"},{"key":"283_CR38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","volume":"33","author":"JW Olney","year":"1999","unstructured":"Olney JW, Newcomer JW, Farber FB (1999) NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33:523\u2013533","journal-title":"J Psychiatr Res"},{"key":"283_CR39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF01400646","volume":"128","author":"S Palaoglu","year":"1994","unstructured":"Palaoglu S, Palaoglu O, Akarsu ES, Ayhan H, \u00d6zgen T, Erbengi A (1994) Behavioural assessment of pinealectomy and foetal pineal gland transplantation in rats. Part II Acta Neurochir 128:8\u201312","journal-title":"Part II Acta Neurochir"},{"key":"283_CR40","first-page":"342","volume":"64","author":"C Revill","year":"1998","unstructured":"Revill C, Kettle A, Holland V, Riley G, Blackburn TP (1998) Role of 5HT receptor in amelioration of extrapyramidal effects of neuroleptics. J Neurosci Res 64:342\u2013360","journal-title":"J Neurosci Res"},{"key":"283_CR41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","volume":"11","author":"ET Robinson","year":"1986","unstructured":"Robinson ET, Becker BJ (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: A review of animal models of amphetamine psychosis. Brain Res Rev 11:157\u2013198","journal-title":"Brain Res Rev"},{"key":"283_CR42","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/sj.npp.1300258","volume":"28","author":"WK Schiffer","year":"2003","unstructured":"Schiffer WK, Logan J, Dewey SL (2003) Positron emission tomography studies of potential mechanisms underlying phencyclidine-induced alterations in striatal dopamine. Neuropsychopharmacology 28:2192\u20132198","journal-title":"Neuropsychopharmacology"},{"key":"283_CR43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00172883","volume":"90","author":"WJ Schmidt","year":"1986","unstructured":"Schmidt WJ (1986) Intrastriatal injection of dl-amino-5-phosphonovaleric acid (AP5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine. Psychopharmacology 90:123\u2013130","journal-title":"Psychopharmacology"},{"key":"283_CR44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0091-3057(89)90007-5","volume":"32","author":"WJ Schmidt","year":"1989","unstructured":"Schmidt WJ, Bubser M (1989) Anticataleptic effects o the NMDA receptor antagonist MK 801 in rats. Pharmacol Biochem Behav 32:621\u2013623","journal-title":"Pharmacol Biochem Behav"},{"key":"283_CR45","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.mp.4001682","volume":"10","author":"P Seeman","year":"2005","unstructured":"Seeman P, Ko F, Tallerico T (2005) Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Mol Psychiatry 10:877\u2013883","journal-title":"Mol Psychiatry"},{"key":"283_CR46","first-page":"1","volume":"2127","author":"H Sershen","year":"2007","unstructured":"Sershen H, Balla A, Aspromonte JM, Xie S, Cooper T, Javitt DC (2007) Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: Implication in NMDA\/glycine mediated dopaminergic dysregulation and dopamine transporter function. Neurochem Int 2127:1\u201311","journal-title":"Neurochem Int"},{"key":"283_CR47","first-page":"243","volume":"25","author":"U Sharma","year":"1997","unstructured":"Sharma U, Roberts ES, Kent UM, Owens SM, Hollenberg PF (1997) Metabolic inactivation of cytochrome P4502BI by phencyclidine: immunochemical and radiochemical analysis of the protective effects of glutathione. Drug Metab Dispos 25:243\u2013250","journal-title":"Drug Metab Dispos"},{"key":"283_CR48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/004982597240532","volume":"27","author":"S Shiiyama","year":"1997","unstructured":"Shiiyama S, Soejima-Ohkuma T, Honda S, Kumagai Y, Cho AK, Yamada H et al (1997) Major role of CYP2C isozymes in deamination of amphetamine and benzphetamine: evidence for the quinidine-specific inhibition of the reactions catalyzed by rabbit enzyme. Xenobiotica 27:379\u2013387","journal-title":"Xenobiotica"},{"issue":"1","key":"283_CR49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0376-6357(03)00028-7","volume":"63","author":"MM Silv\u00e2nia","year":"2003","unstructured":"Silv\u00e2nia MM, Vasconcelos VS, Nascimento CR, Nogueira A, Carlos MA, Vieira G, Franscisca CF, Marta MF, Glauce SB (2003) Effects of haloperidol on rat behavior and density of dopaminergic D2-like receptors. Behav Processes 63(1):45\u201352, 28 May 2003","journal-title":"Behav Processes"},{"key":"283_CR50","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/326698a0","volume":"326","author":"A Stelzer","year":"1987","unstructured":"Stelzer A, Slater T, Bruggencate G (1987) Activation of NMDA receptors blocks GABAergic inhibition in an in vitro model of epilepsy. Nature 326:698\u2013701","journal-title":"Nature"},{"key":"283_CR51","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0269881106073126","volume":"21","author":"JM Stone","year":"2007","unstructured":"Stone JM, Morrison PD, Pilowsky LS (2007) Glutamate and dopamine dysregulation in schizophrenia: a synthesis and selective review. J Psychopharmacol 21:440\u2013452","journal-title":"J Psychopharmacol"},{"key":"283_CR52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-2999(79)90279-6","volume":"59","author":"RD Stugeron","year":"1979","unstructured":"Stugeron RD, Fessler RG, London SF, Meltzer HY (1979) Behavioral ratings for assessing phencyclidine-induced locomotor activity, stereotype behavior and ataxia. Eur J Pharmacol 59:169\u2013179","journal-title":"Eur J Pharmacol"},{"key":"283_CR53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF00430755","volume":"76","author":"RD Stugeron","year":"1982","unstructured":"Stugeron RD, Fessler RG, London SF, Meltzer HY (1982) Behavioral effects of chronic phencyclidine administration in rats. Psychopharmacology (Berl.) 76:52\u201356","journal-title":"Psychopharmacology (Berl.)"},{"key":"283_CR54","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1046\/j.1471-4159.1998.71041443.x","volume":"71","author":"R Takahata","year":"1998","unstructured":"Takahata R, Moghaddam B (1998) Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex. J Neurochem 71:1443\u20131449","journal-title":"J Neurochem"},{"key":"283_CR55","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archpsyc.1995.03950220039008","volume":"52","author":"G Tsai","year":"1995","unstructured":"Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT (1995) Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 52:829\u2013836","journal-title":"Arch Gen Psychiatry"},{"key":"283_CR56","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/syn.10012","volume":"42","author":"H Tsukada","year":"2001","unstructured":"Tsukada H, Nishiyama S, Kakiuchi T, Ohba H, Sato K, Harada N (2001) Ketamine alters the availability of striatal dopamine transporter as measured by [11C]b-CFT and [11C]b-CIT-FE in the monkey brain. Synapse 42:273\u2013280","journal-title":"Synapse"},{"key":"283_CR57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00433256","volume":"71","author":"J Waddington","year":"2004","unstructured":"Waddington J, Gamble S (2004) Spontaneous activity and apomorphine stereotypy during and after withdrawal from continuous administration of haloperidol. J Psychopharmacology 71:75\u201377","journal-title":"J Psychopharmacology"},{"key":"283_CR58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0006-8993(93)90839-F","volume":"622","author":"K Wedzony","year":"1993","unstructured":"Wedzony K, Klimek V, Golembiowska W (1993) MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors. Brain Res 622:325\u2013329","journal-title":"Brain Res"},{"key":"283_CR59","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0301-0082(97)00090-7","volume":"54","author":"ME Wolf","year":"1998","unstructured":"Wolf ME (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog neurobiol 54:679\u2013720","journal-title":"Prog neurobiol"},{"key":"283_CR60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0003-9861(89)90158-6","volume":"273","author":"H Yamada","year":"1989","unstructured":"Yamada H, Honda S, Oguri K, Yoshimura H (1989) A rabbit liver constitutive form of cytochrome P450 responsible for amphetamine deamination. Arch Biochem Biophys 273:26\u201333","journal-title":"Arch Biochem Biophys"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-008-0283-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-008-0283-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-008-0283-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T16:38:41Z","timestamp":1738168721000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-008-0283-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,12]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["283"],"URL":"https:\/\/doi.org\/10.1007\/s00210-008-0283-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2008,4,12]]}}}